New Submissions Are Not Currently Being Accepted
Samples sent after April 10, 2024 will be put on hold.
Viewing desktop version: Switch to Mobile
Unicorn (Pink Tablet)
Sold as: 'Designer Drug'
ID: 8239
Result Photo Detail Photo Detail Photo Detail Photo
ID: 8239
Name: Unicorn
Other Names: Pink Tablet
UniqueCode:More infoUnique Lookup Code is an alphanumeric string created by the submitter and included with the sample so anonymously submitted samples can be positively identified as the submitter's sample. DS192462
Marquis:More infoThe Marquis Test is a reagent field test conducted by placing a drop of reagent liquid onto a small sample of the material being tested. The chemicals in the reagent react differently with different chemicals, turning a variety of colors based on the what is in the material being tested. No Reaction
Mecke:More infoAs with the Marquis Test, The Mecke Test is a reagent field test conducted by placing a drop of liquid reagent onto a sample of the material in question. Mecke reagent is primarily used for the identification of heroin and other opiates. No Reaction
Mandelin:More infoThe Mandelin Test is a reagent field test conducted by placing a drop of liquid reagent onto a sample of the material in question. Mandelin is primarily used for the detection of ketamine and PMA. It is a mixture of ammonium metavanadate and concentrated sulfuric acid. No Reaction
GC/MS:More infoThe GC/MS Lab Test  
Test Date: Feb 07, 2020
Pub. Date: Feb 07, 2020
Src Location: San Francisco, CA
Submitter Loc: Berkeley, CA
United States
Color: Red / Pink
Size: 101 mg, 4.40 mm x 6.40 mm x 4.71 mm
Data Source: DrugsData
Tested by: DDL
Lab's ID: 2020-01-0111
Sold as: 'Designer Drug'
Expected to be: Not Specified
Lab comments:
Tested multiple times. Tableting material (palmitic acid and stearic acid) detected as major components.
Description
Pink tablet fragment, no markings can be discerned on one side, possibly break line on the other side?

Trace ketamine is likely the result of tablet brushing against a speck of ketamine before arriving at the lab. It is unlikely that the tablet contained psychoactive amounts of ketamine.

Sender describes sample as 'New-to-the-scene designer drug being marketed as 'unicorn' -- molecular makeup/components unknown.'

Ecstasy/Molly tablets must be whole tablets, partial tablets are not eligible for the same co-pay.
Problem
With only part of a tablet submitted, it would be theoretically possible that the other half of the tablet would have revealed something different under GC/MS. Please send whole tablets!

If you know whether anybody ingested a tablet like this and experienced effects, please let us know!